Company news
Zhongchao Inc. (NASDAQ:ZCMD) news
Zhongchao Inc. news releases on 6ix. Latest, Sep 30, 2026: Zhongchao Inc. Announces 1-for-2 Share Consolidation
Press releases & updates
Zhongchao Inc. Announces 1-for-2 Share Consolidation
September 30, 2026
Zhongchao Inc. Announces $5.0 Million Registered Direct Offering
July 23, 2026
Zhongchao Inc. Announces 1-for-3 Share Consolidation
June 25, 2026
Zhongchao Inc. Announces 1-for-31 Share Consolidation
June 3, 2026
Zhongchao Inc. Announces Pricing of $5 Million Best Efforts Public Offering
May 29, 2026
Zhongchao Inc. Announces 1-for-8 Share Consolidation
February 26, 2026
Zhongchao : Securities Purchase Agreements Form 6 K
December 13, 2024
Zhongchao : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS Form 6 K
November 6, 2024
Zhongchao : Unaudited Interim Consolidated Financial Statements as of June 30, 2024 and for the Six Months Ended June 30, 2024 and 2023 Form 6 K
November 1, 2024
Zhongchao : Entry into Material Definitive Agreement Form 6 K
October 2, 2024
Zhongchao : Has Regained Compliance with Nasdaq’s Minimum Bid Price Deficiency - Form 6-K
March 18, 2024
Zhongchao Inc. Announces Successful Medication Assistance Services for Over 7,000 SLE Patients with Approximately 130,000 Units of Medications
March 11, 2024
Zhongchao Inc. Announces 1-for-10 Share Consolidation
February 26, 2024
Zhongchao : NASDAQ Notification Regarding Minimum Bid Price Deficiency - Form 6-K
January 3, 2024
ZHONGCHAO : UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS - Form 6-K
December 22, 2023
Zhongchao Inc. Collaborates with a Public Health Foundation to Support Sustainable and Effective Cancer Treatments
December 10, 2023
Zhongchao Inc. Launches Breast Cancer Follow-up Visit and Health Management Patient Guide Program on Breast Cancer Awareness Day
October 22, 2023
Zhongchao Inc. Introduces PRO-Based Disease Management Model for Lung Cancer Patients
September 24, 2023
Zhongchao Inc. Announces Serving over 10,000 Breast Cancer Patients with Its Comprehensive Disease Management
August 23, 2023
Zhongchao Inc. Partners with Ximalaya to Launch the First Audio Course Series for Cancer Education
July 10, 2023
Zhongchao Inc. Launch Digital Online Education Platform for Common Diseases Clinical Diagnosis and Treatment
June 11, 2023
Zhongchao : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS - Form 6-K
May 23, 2023
Zhongchao Inc. Announces Strategic Cooperation with Ximalaya
May 11, 2023
Zhongchao Inc. Announces Naiditawei® Enrolled as a Listed Online Procurement Drug in Ten Provinces(Districts, Cities) in China
May 7, 2023
Zhongchao Inc. Partners with a Public Health Foundation to Safeguard Cancer Patients' Health
April 23, 2023
Zhongchao Inc. Announces Launch of Health Education Intelligent Content Production Platform
March 29, 2023
Zhongchao Inc. Releases Survey Results for Bone Marrow Cancer Patient Services with More than 80% Patients Indicating Full Satisfaction
March 12, 2023
Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)
February 22, 2023
Zhongchao Inc. Announces the Application of ChatGPT for Its MDMOOC Platform to Assist Physicians in Clinic Decision Making and Improve Treatment Efficiency
February 12, 2023
Zhongchao Inc. Announces the Application of ChatGPT to Elevate Patient Management Service Capabilities and Experience
February 7, 2023
Zhongchao Inc. Announces Introduction of Indian Anti-influenza Drugs to China
January 30, 2023
Zhongchao Inc. Launches Medication Management Assistance Mini Program to Facilitate Cancer Treatment
January 18, 2023
Zhongchao Inc. Announces Drug Distributorship in China of Indian Generic Drugs of Natco Pharma Limited
January 3, 2023
Zhongchao Inc. Established SID Liver Cancer Comprehensive-Disciplinary Physician Education Platform
December 4, 2022
Zhongchao Inc.'s China Operating Entity, Chongqing Xinjiang Pharmaceutical Co., Ltd. Obtained Pharmaceutical Trade and Medical Device Operation Licenses, Ready to Enter Into Pharmaceuticals Circulation Market
November 2, 2022
Zhongchao Inc. Establishes Chongqing Xinjiang Pharmaceutical Co., Ltd. to Improve Patient Access to Medications
September 27, 2022
Zhongchao Inc. Establishes Zhixun Internet Hospital to Provide Patient with Management Services Focusing on the Oncology and Other Major Diseases
September 14, 2022
Zhongchao Inc. Announces its New Strategy Extension Focusing on the Oncology and Other Major Disease Management
August 31, 2022
Zhongchao Inc. Announces its MDMOOC Platform Launched Disease Prevention and Distribution Quality Management Course
June 12, 2022
Zhongchao Inc. Reports the Fiscal Year 2021 Financial Results
May 8, 2022
Zhongchao Inc. Announces Its Patient Management System Improves Its Liver Cancer Patients' Duration of Therapy by 40%, Promoting Successful Treatment
October 28, 2021
Zhongchao Inc. Launches Hematology MDT Training Platform to Improve Diagnosis and Treatment
September 16, 2021
Zhongchao Inc. Announces Hematological Tumor Patient Management Business to Further Expand to Out-of-Hospital Market
September 9, 2021
Zhongchao Inc. Expands Patient Management Business to Ovarian Cancer Market
August 24, 2021
Zhongchao Inc. Builds A Patient DOT Management System
August 11, 2021
Zhongchao Inc. Builds A Platform for Breast Cancer Tiered Diagnosis and Treatment Improvement To Promote the Equalization of Breast Cancer Diagnosis and Treatment Level
July 26, 2021
Zhongchao Inc. Announces the Establishment of a New Subsidiary Ningxia Zhongxin Internet Hospital Co., Ltd. for Patient Management
June 30, 2021
Zhongchao Inc. Partners with a Subsidiary of AbbVie Inc. (NYSE: ABBV) for Medical Education Services
June 15, 2021
Zhongchao Inc. Announces the On-Going One-Year Leukemia Education Project with Bethune Foundation and BeiGene Shanghai
June 2, 2021
Zhongchao Inc. Launched New Line of Business Focusing on Tumor and Rare Disease Patient Management
May 27, 2021